19
Sanofi, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their notable products is RIFAMPIN, with a corresponding application number 50627.
Regulatory Information RX
With a dosage strength 600MG/VIAL
Dosage Form Route INJECTABLE; INJECTION
Reference Listed Drug Yes
Approved since 1989-05-25
Therapeutic Equivalence (TE) Code AP